Brainstorm Cell Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 11/14/2024 | 6.90 M | $1.59 M | -12.88% | 9.69% |
| VANGUARD GROUP INC | 11/13/2024 | 1.51 M | $347,447 | 0.00% | 2.12% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 682,816 | $151,962 | 40.99% | 0.96% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 377,611 | $86,964 | 100.00% | 0.53% |
| LIBERTY WEALTH MANAGEMENT LLC | 11/04/2024 | 340,150 | $78,000 | 0.00% | 0.48% |
| WEAVER CONSULTING GROUP | 11/14/2024 | 234,356 | $53,972 | 0.00% | 0.33% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 127,400 | $29,340 | -1.39% | 0.18% |
| STATE STREET CORP | 11/14/2024 | 117,260 | $27,005 | 0.00% | 0.16% |
| RAYMOND JAMES & ASSOCIATES | 10/18/2024 | 95,153 | $21,914 | -14.50% | 0.13% |
| JMAC ENTERPRISES LLC | 10/31/2024 | 65,430 | $15,069 | 0.00% | 0.09% |
| XTX TOPCO LTD | 11/14/2024 | 53,088 | $12,226 | 100.00% | 0.07% |
| WELLS FARGO & COMPANY/MN | 11/13/2024 | 52,777 | $12,154 | 83.18% | 0.07% |
| MORGAN STANLEY | 11/14/2024 | 49,463 | $11,391 | 33.77% | 0.07% |
| GROUP ONE TRADING, L.P. | 11/14/2024 | 46,754 | $10,767 | 0.00% | 0.07% |
| TRU INDEPENDENCE ASSET MANAGEMENT 2, LLC | 11/04/2024 | 44,000 | $10.13 M | 100.00% | 0.06% |
| CITADEL ADVISORS LLC | 11/14/2024 | 32,900 | $7,577 | -17.75% | 0.05% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 23,356 | $5,372 | -73.02% | 0.03% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 23,000 | $5,297 | -1.71% | 0.03% |
| JANNEY MONTGOMERY SCOTT LLC | 10/29/2024 | 20,500 | $5,000 | 0.00% | 0.03% |
| TWO SIGMA SECURITIES, LLC | 11/14/2024 | 19,796 | $4,559 | -80.60% | 0.03% |
| CREATIVE PLANNING | 10/11/2024 | 13,846 | $3,189 | -33.83% | 0.02% |
| SAXONY CAPITAL MANAGEMENT, LLC | 10/22/2024 | 12,950 | $2,982 | 0.00% | 0.02% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 11,994 | $2,762 | 0.00% | 0.02% |
| JUMP FINANCIAL, LLC | 11/14/2024 | 10,995 | $2,532 | 100.00% | 0.02% |
| ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 10,519 | $2,419 | 0.00% | 0.01% |
| CITADEL ADVISORS LLC | 11/14/2024 | 7,500 | $1,727 | 4.17% | 0.01% |
| ACTIVEST WEALTH MANAGEMENT | 11/12/2024 | 5,010 | $1,154 | -29.24% | 0.01% |
| BANGOR SAVINGS BANK | 10/07/2024 | 4,000 | $921 | 0.00% | 0.01% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 11/14/2024 | 2,700 | $622 | 0.00% | 0.00% |
| UBS GROUP AG | 11/14/2024 | 2,501 | $575 | -64.82% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 1,607 | $370 | 7.71% | 0.00% |
| CLEARSTEAD ADVISORS, LLC | 11/13/2024 | 1,500 | $346 | 0.00% | 0.00% |
| REUTER JAMES WEALTH MANAGEMENT, LLC | 11/08/2024 | 1,034 | $238 | 100.00% | 0.00% |
| WESTSIDE INVESTMENT MANAGEMENT, INC. | 11/20/2024 | 200 | $46 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 11/08/2024 | 175 | $40 | -31.37% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 11/12/2024 | 161 | $37 | 0.00% | 0.00% |
| ST GERMAIN D J CO INC | 10/18/2024 | 0 | $0 | -100.00% | 0.00% |
| ABNER HERRMAN & BROCK LLC | 10/08/2024 | 0 | $0 | -100.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2024 | 0 | $0 | -100.00% | 0.00% |
| LPL FINANCIAL LLC | 11/08/2024 | 0 | $0 | -100.00% | 0.00% |
| SIMPLEX TRADING, LLC | 11/08/2024 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 11/20/2024 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 11/15/2024 | 0 | $0 | -100.00% | 0.00% |
| CRANBROOK WEALTH MANAGEMENT, LLC | 10/15/2024 | 0 | $0 | -100.00% | 0.00% |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | 11/08/2024 | 0 | $0 | -100.00% | 0.00% |
| MARK SHEPTOFF FINANCIAL PLANNING, LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| FIRST AFFIRMATIVE FINANCIAL NETWORK | 10/10/2024 | 0 | $0 | -100.00% | 0.00% |
| EVERSOURCE WEALTH ADVISORS, LLC | 11/08/2024 | 0 | $0 | -100.00% | 0.00% |
| VISIONPOINT ADVISORY GROUP, LLC | 10/15/2024 | 0 | $0 | -100.00% | 0.00% |
| 11/25/2024 | 0 | $0 | -100.00% | 0.00% |
Brainstorm Cell Therapeutics Inc.institutional Ownership - FAQ's
During the previous two years, 66 institutional investors and hedge funds held shares of Brainstorm Cell Therapeutics Inc.. The most heavily invested institutionals were:
ARMISTICE CAPITAL, LLC: 6.9 M
VANGUARD GROUP INC: 1.51 M
GEODE CAPITAL MANAGEMENT, LLC: 682,816
BlackRock Funding, Inc. /DE: 377,611
LIBERTY WEALTH MANAGEMENT LLC: 340,150
Weaver Consulting Group: 234,356
15.20% of Brainstorm Cell Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 11.29 M shares in the last 24 months. This purchase volume represents approximately $25.62 M in transactions.